Brought to you by:
-
‘Vigilant’ surveillance and low threshold for further interventions ‘crucial’ following rescue of prior EVAR with PMEG
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index aneurysm repair and following prior EVAR led researchers to conclude that “vigilant” surveillance and a low threshold for further interventions are “crucial.” The finding relates to PMEG for rescue of prior…
-
SVS announces new vice president and treasurer following 2023 election
The Society for Vascular Surgery (SVS) has announced the latest additions to its officer roll following the 2023 elections for Society vice president and treasurer. Keith Calligaro, MD, of Pennsylvania Hospital and a professor of clinical surgery at the University of Pennsylvania School of Medicine in Philadelphia, was elected vice president for 2023–24, meaning he…
-
Nephrologist insights for vascular surgeons at hemodialysis access session
Friday afternoon in Potomac D will see VAM play host to a series of presentations on access for hemodialysis that will offer education on arteriovenous fistulas (AVFs), grafts (AVGs) and maturation—as well as strategies for managing their failure. The session will be moderated by Maureen Sheehan, MD, of Wake Forest University Medical Center, North Carolina,…
-
‘Excellent’ limb salvage rates for trauma bypass performed by vascular surgeons
Revascularization for extremity trauma can be performed with excellent limb salvage rates, though poor compliance with long-term surveillance raises some cause for concern. These are among the primary messages presented from a study detailing the experience and outcomes of a rural, level one, trauma center performing upper- or lower-extremity revascularization in trauma patients over a…
-
Improved fistulas and cost-effectiveness promised in plenary 5 abstract presentation
Friday morning’s Plenary Session 5 (8:00–9:30 a.m.) is set to feature new data on an external support device that may deliver more functional arteriovenous fistulas (AVFs) while also offering an improvement in cost-effectiveness. Presenting an abstract on research into the VasQ device will be Ellen D. Dillavou, MD, of WakeMed Hospital in Raleigh, North Carolina.…
-
Last hours to bid on Gala Auction items
A night of grandeur, reminiscent of the parties hosted by the fictional character Jay Gatsby, awaits attendees on tonight (Friday) at the “Great Gatsby Gala,” benefiting the SVS Foundation. Gala tickets are sold out, but bidding will continue for everyone regardless of VAM or Gala attendance. More than 50 items are available, including weekend excursion…
-
Presidential handover at VAM 2023
The annual business meeting (for members only). The results of the just completed SVS election of officers (vice president and treasurer) will be announced at the meeting, which will also feature reports from officers and others, presentation of awards and the passing of the gavel—and the SVS presidency—from Michael C. Dalsing, MD, to Joseph Mills,…
-
BEVAR, F-BEVAR, FEVAR, Fiber Optic RealShape, FORS, Imaging, Philips’ Fiber Optic RealShape, VAM 2023
Future research needed to ‘optimize’ use of imaging technologies during aortic procedures
Imaging technologies in the aortic space will be a key feature of Saturday’s Plenary Session 8 (11:15 a.m. to 12:30 p.m.) in Potomac A/B, with speakers set to share data on Philips’ Fiber Optic RealShape (FORS) technology and Centerline Biomedical’s IntraOperative Positioning System (IOPS). Valeria Mejia-Martinez, BS, a medical student at the University of Texas…
-
Study shows performance on the vascular qualifying examination does not predict performance on the certifying examination
A national cohort study of vascular trainees taking the Vascular Qualifying Examination (VQE) and the Vascular Certifying Examination (VCE) found performance during the former is “not predictive” of first-time pass achievement in the latter—but, the findings highlight the “[necessary]” identification of trainee competency measures that may predict certification examination failure. Speaking to VS@VAM ahead of…
-
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data indicating its potential in stabilising or slowing AAA sac growth. According to Stephen Cheng, MBBS, MS, chair of the Department of Surgery at the University of Hong Kong, these first-in-human study…